In addition, several studies have shown that PTPN12 is linked to a favorable prognosis in TNBC patients by suppressing multiple oncogenic tyrosine kinases, including HER2 and EGFR, thereby dampening breast cancer cell survival, migration and EMT (150–152). Here, ERBB2 is linked to breast carcinoma.